{{Rsnum
|rsid=7926920
|Gene=LOC100288077
|Chromosome=11
|position=102827993
|Orientation=plus
|GMAF=0.3985
|Gene_s=COX6CP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.9 | 50.4 | 17.7
| HCB | 10.9 | 40.9 | 48.2
| JPT | 8.0 | 38.1 | 54.0
| YRI | 19.7 | 51.7 | 28.6
| ASW | 22.8 | 54.4 | 22.8
| CHB | 10.9 | 40.9 | 48.2
| CHD | 13.8 | 42.2 | 44.0
| GIH | 6.9 | 35.6 | 57.4
| LWK | 12.7 | 50.0 | 37.3
| MEX | 10.3 | 44.8 | 44.8
| MKK | 15.4 | 39.7 | 44.9
| TSI | 23.5 | 47.1 | 29.4
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs7926920
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:20031604
|Annotation=In a GWAS performed on 778 healthy Amish adults, this SNP was significantly associated with levels of circulating MMP1. Phenotype: associated with circulating MMP1 levels. Study size:778. Study population/ethnicity: healthy Amish adults. Significance metric(s): P value: GC content -corrected p = 4.75 x 10 (-18). Type of association: CO; GN.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Curated
|PharmGKB Accession ID=PA165111636
}}

{{PMID Auto
|PMID=19318431
|Title=No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7926920
|overall_frequency_n=53
|overall_frequency_d=120
|overall_frequency=0.441667
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=48
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}